|
|
GLOSSARY
|
|
Per protocol analysis
|
|
|
SPOT ON
|
|
Surrogate endpoints to evaluate benefit in oncology
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
POET-COPD: tiotropium superior to salmeterol
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
SHIFT study: reevaluation of ivabradine necessary?
UCB: the same with differences
|
|
|
IN BRIEF
|
|
Diuretic strategies for decompensated heart failure
Long-acting risperidone in schizophrenia
Lavender oil (LASEA) and the German Medical Products Advertising Act
Medical journals: influence of funding sources on the content
Cave: vfa brochure - ideal pharmaceutical world for teenagers
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Angioedema due to saxagliptin (ONGLYZA)?
|
|
Nightmares, depression with dronedarone (MULTAQ)
|
|
|
SIDE EFFECTS
|
|
Increased cardiovascular mortality with olmesartan
|
|
|
e a-t IN THE INTERNET
|
|
Lavender oil (LASEA): Spitzner comments on the a-t article
|
|